Income Tax Expense (Benefit) of LENZ Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
LENZ Therapeutics, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • LENZ Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.
  • LENZ Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $1,000.
  • LENZ Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $179,000.
  • LENZ Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

LENZ Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $500,000 +$500,000 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $0 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2

LENZ Therapeutics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,000 +$180,000 01 Jan 2024 31 Dec 2024 10-K 19 Mar 2025 2024 FY
2023 $179,000 -$179,000 01 Jan 2023 31 Dec 2023 10-K 19 Mar 2025 2024 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2023 2022 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023 2022 FY
2020 $0 01 Jan 2020 31 Dec 2020 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.